acetylcysteine has been researched along with Iron Metabolism Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, JK; Jankovic, J; Kaur, D; Le, W; Li, X; Luo, F; Xie, W; Zhu, W | 1 |
Jankovic, J; Kansara, S; Le, WD; Li, XP; Xie, WJ; Zhang, Z | 1 |
2 other study(ies) available for acetylcysteine and Iron Metabolism Disorders
Article | Year |
---|---|
Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
Topics: Acetylcysteine; Animals; Apoferritins; Cation Transport Proteins; Chelation Therapy; Corpus Striatum; Cysteine Proteinase Inhibitors; Cytoprotection; Dopamine; Gene Expression Regulation; Genetic Therapy; Iron Metabolism Disorders; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra | 2010 |
A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration.
Topics: Acetylcysteine; Antigens, CD; Blotting, Western; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; Dopaminergic Neurons; Ferritins; Genetic Vectors; Humans; Immunoprecipitation; Iron; Iron Metabolism Disorders; Iron-Regulatory Proteins; Lentivirus; Nerve Degeneration; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Receptors, Transferrin; RNA, Small Interfering | 2012 |